1Steer P. The epidemiology of preterm labour [ J ]. B JOG, 2005,112(Suppl 1): 1 -3.
2Segel SY , Miles AM, Clothier B,et al. Duration of antibiotic therapy after preterm premature rupture of fetal membranes[ J]. Am J Obstet Gynecol,2003,189 (3) : 799 - 802.
3Yaju Y, Nakayama T. Effectiveness and safety of ritodrine hydrochloride for the treatment of preterm labour: a systematic review [ J ]. Pharmacoepidemiol Drug Saf,2006,15 ( 11 ) : 813 - 822.
4Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants [ J]. Am J Obstet Gynecol, 2002, 186 (6):1 -11.
5King J F , Flenady VJ , Papatsonis DNM , et al. Calcium channel blockers for inhibiting preterm labour [ J ]. Cochrane Database Syst Rev, 2003,1 ( 1 ) : CD002255.
6Zlatnik MG,Copland JA , Ires K, et al. Functional oxytocin receptors in a human endometrial cell line [ J ]. Am J Obstet Gynecol, 2000,182(4) : 850 -855.
7Torsten M Reinheimer. Barusiban suppresses oxytocin-induced preterm labour in non-human primates. [ J ]. BMC Pregnancy Childbirth, 2007,7 ( Suppl 1 ) : S15.
8Husslein P, Cabero Roura L, Dudenhausen JW, et al. Atosiban versus usual care for the management of preterm labor [ J ]. J Perinat Med, 2007,35 (4) : 305 -313.
9Shim JY, Park YW, Yoon BH, et al. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women [ J ]. B JOG, 2006,113 ( 11 ) : 1228 - 1234.
10Valenzuela GJ , Sanchez Ramos L, Romero R , et al . Maintenance treatment of pretermlabor with the oxytocin antagonist atosiban [ J ]. Am J Obstet Gynecol, 2000,182:1184 - 1190.
10Berghella V,Owen J,Phersnn C,et al.Natural historyo cervical funneling in women at high risk for spontaneous preterm birth[J].Obstet Gynecol,2007,109(4):863-869.
